Propafenone for the Treatment of Supraventricular Tachycardia and Atrial Fibrillation: A Meta-Analysis

American Journal of Cardiology

Volumn 82, Issue 7 A, 1998, Pages 66N-71N

  Reimold, Sharon C ^a   Maisel, William H ^a   Antman, Elliott M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROPAFENONE;

CARDIOVERSION; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; HEART ATRIUM FIBRILLATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENT DISEASE; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; HUMANS; PROPAFENONE; RESEARCH DESIGN; TACHYCARDIA, SUPRAVENTRICULAR; TIME FACTORS;

EID: 0031766856     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00587-6     Document Type: Article

References (70)

1. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a meta-analysis of randomized controlled trials. Circulation 1990;82:1106-1116.
2. Cochran WG. The combination of estimates from different experiments. Biometrics 1954;10:101-129.
3. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
4. Reimold SC, Chalmers TC, Berlin JA, Antman EM. Assessment of the efficacy and safety of antiarrhythmic therapy for chronic atrial fibrillation: observations on the role of trial design and implications of drug-related mortality. Am Heart J 1992;124:924-932.
5. Beck OA, Krämer K-D, Wolf R, Müller A, Hochrein H. Propafenone, a new antiarrhythmic agent for the treatment of ectopic and rapid cardiac arrhythmias. Med Klin 1975;70:95-101.
6. Beck OA, Hochrein H. Effects and risks of antiarrhythmia treatment with propafenone (German). Dtsch Med Wochenschr 1978;32:1261-1265.
7. Menozzi C, Lolli G, Gheller G, Monducci I, Vergoni W, Cattabiani ML, Manenti E, Casali G. The use of propafenone in short and long term treatment of supraventricular and ventricular arrhythmia (Italian). Clin Ter 1983;105:125-133.
8. Shen EN, Keung E, Huycke E, Dohrmann ML, Nguyen N, Morady F, Sung RJ. Intravenous propafenone for termination of reentrant supraventricular tachycardia. Ann Intern Med 1986;105:655-661.
9. Çeliker A, Özer S, Özme, Özkutlu S, Kahramanyol Ö. Experience with propafenone for the treatment of cardiac arrhythmias in children. Turk J Pediatr 1990;32:85-92.
10. Iturralde P, Nunura F, Romera L, Colin L, Rosado J, Galvan O, de Micheli A, Gonzalez-Hermosillo J, Casanova JM. Efecto electrofisiologico de propafenona endovenosa en las taquicardias supraventriculares. Arch Inst Cardiol Mex 1991;61:135-141.
11. Rostagno C, Paladini B, Pini C, Taddei T, Russo L, Giglioli C, Margheri M, Bertini G. Feasibility of out-of-hospital treatment of supraventricular tachycardias. Am J Cardiol 1991;68:119-122.
12. Bossi M, Tisi G, Baroffio R, Guzzini F. Efficacy and safety of propafenone in the emergency treatment of the supraventricular arrhythmias. L = information. Cardiologique 1992;16:528-536.
13. Vergara C, Dal Forno P, Disertori M, Bettini R, Stirpe E, Furianello F. Use of propafenone in patients with paroxysmal supraventricular reciprocating tachycardias. (Abstr.) Eur Heart J 1984;5(suppl 1):1152.
14. Farre J, Grande A, Hernandez R, Rabago P. Effects of propafenone on accessory pathways and circus move ment tachycardias. (Abstr.) Eur Heart J 1984;5(suppl 1):1153.
15. Furlanello F, Vergara G, Dal Forno P, Disertori M, Inama G. Esperienza clinica con il propafenone nelle tachicardie parossistiche sopraventricolari reciprocanti. G Ital Cardiol 1984; 14:379-380.
16. Musto B, D'Onofrio A, Musto A, Cavallaro C, Marsico F. Electrophysiologic effects and clinical efficacy of propafenone in patients in pediatric age with recurrent paroxysmal supraventricular tachycardia. G Ital Cardiol 1986;16:336-343.
17. Sirinelli A, Maarek-Charbit M, Motte G. Efficacite et tolerance de la propafenone dans la prevention a un an des recidives d'arythmies auriculaires. Ann Cardiol Angeiol (Paris) 1992;41:419-423.
18. Chimienti M, Cullen MT Jr, Casadei G, for the Flecainide and Propafenone Italian Study Investigators. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Eur Heart J 1995;16:1943-1951.
19. UK Propafenone PSVT Study Group. A randomized, placebo-control led trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. Circulation 1995;92:2550-2557.
20. Carerj S, Cavalli G, Magazu, Carerj B, Cento D, Arrigo F, Oreto G, Consolo F. Trattamento della fibrillazione atriale recente mediante propafenone per via venosa. Cardiologia 1989;34:83-85.
21. Pardini E, Tognarini S, Piacentini M. Comparison between flecainide and propafenone in sinusal rhythm conversion of atrial flutter/fibrillation with recent onset. (Abstr.) Cardiologia 1989;34(suppl 5):83.
22. Kondili A, Kastrati A, Popa V. Comparative evaluation of verapamil, flecainide, and propafenone for the acute conversion of atrial fibrillation into sinus rhythm. Wien Klin Wochenschr 1990;102:510-513.
23. Suttorp MK, Kingma JH, Jessurun ER, Lie-a-huen L, van Hemel NM, Lie KI. The value of class Ic antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol 1990;16:1722-1777.
24. Goy J-J, Metrailler J-C, Humai L, de Torrente A. Resoration of sinus rhythm in atrial fibrillation of recent onset using intravenous propafenone. Am Heart J 1991;122:1788-1790.
25. Capucci A, Rubino I, Boriani G, Della Casa S, Sanguinetti M, Magnani B. A placebo controlled study comparing oral propafenone to quinidine plus digoxin in conversion of recent onset atrial fibrillation. (Abstr.) Eur Heart J 1991;12:388.
26. Lavange S, Lolli G, Mendia R, Sanna GP. Efficacy of i.v. boli of propafenone in converting persistent paroxysmal atrial fibrillation to sinus rhythm. (Abstr.) Circulation 1991;84:II-126.
27. Balducelli M, Facore M, Maresta A. Flecainide and propafenone in the treatment of paroxysmal atrial fibrillation. (Abstr.) Cardiovasc Drugs Ther 1991; 5:359.
28. Negrini M, Gibelli G, De Ponti C. Intravenous propafenone versus amiodarone for acute conversion of recent onset atrial fibrillation. (Abstr.) Cardiovasc Drugs Ther 1991;5:365.
29. Margheri M, Fradella G, Maioli M, Paitrio M, Bartoli P, Bonechi F, Brandinelle F, Sansoni M, Zipoli A, Ieri A. Efficacia del propafenone e.V. e per os nel trattamento ambulatoriale della fibrillazione atriale de recente insorgenza. G Ital Cardiol 1992;22:257-265.
30. Baldi N, Lenti V, Marasco G, Russo VA, Montervino C. Propafenone vs flecainide in the acute treatment of atrial fibrillation of recent onset: a randomized study. New Trends Arrhythmias 1992;10:499-505.
31. Lavanga S, Sanna GP. Repeated i.v. boluses of propafenone for acute atrial fibrillation: A randomized placebo-controlled trial. (Abstr.) Circulation 1992; 86(suppl I):2642.
32. Liguori AM, Di Ieso N, D'Armiento FP, Furia L, Napoli C, Bruzzese G, Piatto A, Varriale A. Intravenous propafenone for suppression of symptomatic atrial fibrillation and atrial flutter in a first aid hospital. Eur Rev Med Pharm Sci 1992; 14:229-232.
33. Kingma JH, Suttorp MJ. Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil. Am J Cardiol 1992;70(suppl):56A-61A.
34. Palmiere N. Bracchetti. Safety and efficacy of i.v. propafenone in conversion of paroxysmal atrial fibrillation of recent onset. (Abstr.) Circulation 1992; 86(suppl I):2644.
35. Capucci A, Lenzi T, Boriani G, Rubinio I, Margotti R, Trisolino SSG, Binetti N, Della Casa S, Sanguinetti M, Magnani B. Efficacy of propafenone to convert atrial fibrillation to sinus rhythm: a controlled study comparing acute intravenous infusion vs oral loading. (Abstr.) Circulation 1992;88:I445.
36. Bellandi F, Cantini F, Pedone T, Dabizzi RP, Palchetti R. Efficacia del propafenone e dell'amiodarone endovena nella conversione della fibrillazione atriale recente. Follow-up di 1 anno contrattamento orale. G Ital Cardiol 1993; 23:261-271.
37. Botto GL, Falcone C, Bonini W, Broffoni T, Espurso M, Jemoli R, Molteni S, Ferrari G. Conversion of recent onset atrial fibrilation to sinus rhythm using a single oral loading dose of propafenone: a single-blind controlled study. (Abstr.) Circulation 1993;88:I66.
38. Cihangir U, Mustafa O, et al. Comparison of propafenone and flecainide in conversion of acute atrial fibrillation and flutter to sinus rhythm. Bull Gulhane Med Acad 1993;35:673-679.
39. Roccaforte R, Micoli T, Peci P, Giani P. Efficacy of a slow rate infusion of propafenone on the restoration of sinus rhythm in atrial fibrillation. 5th International Symposium on Cardiovascular Pharmacotherapy. 1993:237.
40. Capucci A, Boriani G, Botto GL, Lenzi T, Rubino I, Falcone C, Trisolino G, Casa SD, Binetti N, Cavazza M, Sanguinetti M, Magnani B. Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide. Am J Cardiol 1994;74:503-505.
41. Weiner P, Ganam R, Ganem R, Zudab F, Rabner M. Clinical course of recent-onset atrial fibrillation treated with oral propafenone. Chest 1994;105: 1013-1016.
42. Proclemer A, Miorelli M, Pavan P, Vicentini A, Morgera T, Pavan D. Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. JAm Coll Cardiol 1994;949-982.
43. Negrini M, Gibelli G, de Ponti C. A comparison of propafenone and amiodarone in reversion of recent-onset atrial fibirllation to sinus rhythm. Curr Ther Res 1004;55:1345-1354.
44. Boriani G, Capucci A, Lenzi T, Sanguinetti M, Magnani B. Propafenone for conversion of recent-onset atrial fibrillation. Chest 1995;108:355-358.
45. Stroobandt R, Stiels B, Hoebrechts R. Propafenone for conversion and prophylaxis of atrial fibrillation. Am J Cardiol 1997;79:418-423.
46. Botto GL, Capucci A, Bonini W, Boriani G, Broffoni T, Barone P, Espureo M, Lombardi R, Molteni S, Ferrari G. Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens. Int J Cardiol 1997;58:55-61.
47. Trittin G, Mannebach H, Ohlmeier H. Long-term stabilizing of rhythm: reexamination sheds light upon long-term tolerability and efficacy of an oral antiarrhythmic drug. Aerztl Praxis 1982;34:3084-3086.
48. Bounhoure JP, Sabot G, Cassagneau B, Calazel J, Dechandol AM. Étude de la propafénone orale dans les arythmies auriculaires rebelles. Ann Cardiol Angeiol (Paris) 1985;34:485-488.
49. Haissaguerre M, Wicker F, Goldrach S, Vrancea F, Regaudie J-J, Metayer LE, Warin J-F, Blanchot P. La propafénone orale dans les arythmies rebelles. Ann Cardiol Angeiol (Paris) 1986;35(3):173-179.
50. Bellocci F, Nobile A, Spampinato A, Naya S, Montenero S, Zecchi P. Oral propafenone for prevention of recurrent primary atrial fibrillation: predictive value of the response to transesophageal atrial stimulation. (Abstr.) J Am Coll Cardiol 1989;13:233A.
51. Boutaud P, Guillem JP, Maarek-Charbit M, Amiel A, Ciber M, Herpin D, Demange J. Efficacité antiarythmique de la propafénone per os dans la prévention des arythmies paroxystiques supraventriculaires résistantes aux agents de la classe la. Ann Cardiol Angeiol 1989;38:37-42.
52. Connolly SJ, Hoffert DL. Usefulness of propafenone for recurrent paroxysmal atrial fibrillation. Am J Cardiol 1989;63:817-819.
53. Gaita F, Greco C, Biagioli F, Richiardi E, Brusca A. Atrial fibrillation: propafenone versus quinidine in the long-term prophylaxis. (Abstr.) Eur Heart J 1989;10(suppl 506):102.
54. Kyles AE, Murdock CJ, Yeung-Lai-Wah JA, Vorderbrugge S, Kerr CR. Long-term efficacy of propafenone for prevention of atrial fibrillation. Can J Cardiol 1991;7:407-409.
55. Aggelakas S, Tsingas D, Aggelakas E, Miadis A. Long-term oral propafenone therapy for suppression of refractory symptomatic fibrillation and atrial flutter. (Abstr.) Cardiovasc Drugs Ther 1991;5:359.
56. Lopez Gil M, Karoni AW, Reinoso MA, Garcia-Cosio MF. Eficacia de la propafenona en la prevencion de fibrilacion y fluter auricular recurrente. Rev Esp Cardiol 1991;44:435-440.
57. Richiardi E, Gaita F, Grecco C, Gaschino G, Costa GC, Rosettani E, Brusca A. Propafenone versus quinidine in long-term prophylaxis of atrial fibrillation. Cardiologia 1992;37:123-127.
58. Reimold S, Cantillon CO, Friedman PL, Antman EM. Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. Am J Cardiol 1993;71:558-563.
59. Kerr CR, Mason MA, Chung DC. Propafenone: an effective drug for prevention of recurrent atrial fibrillation. (Abstr.) Circulation 1985;72(suppl III):8515.
60. Hammill S, Wood D, Sugrue D, Gersh B, Osborn M, Holmes D. Propafenone for chronic treatment of paroxysmal atrial fibrillation. Circulation 1985;72(suppl III):.
61. Lee S-H, Chen S-A, Tai C-T, Chiang C-E, Wen Z-C, Chen Y-J, Yu W-C, Huang J-L, Fong A-N, Cheng J-J, Chang M-S. Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation. Am J Cardiol 1997;79:905-908.
62. Lee SH, Chen SA, Chiang CE, Tai CT, Wen ZC, Wang SP, Chang MS. Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial. J Intern Med 1996;239:253-260.
63. Tarquinii M, Lolli C, Toschi GP, Annicchiarico M, Sirola D, Labriola E. Profilassi della fibrillazione atriale parossistica con propafenone. Clin Ter Cardiovasc 1001;2:111-114.
64. Antman EM, Beamer AD, Cantillon C, McGowan N, Friedman PL. Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs. J Am Coll Cardiol 1990;15:698-707.
65. Porterfield JG, Porterfield LM. Therapeutic efficacy and safety of oral propafenone for atrial fibrillation. Am J Cardiol 1989;63:114-116.
66. Winniford MD, Fulton KL, Hillis LD. Long-term therapy of paroxysmal supraventricular tachycardia: a randomized, double-blind comparison of digoxin, propranolol and verapamil. Am J Cardiol 1984;54:1138-1139.
67. Jackman WM, Beckman KJ, McClelland JH, Wang X, Friday KJ, Roman CA, Moulton KP, Twidale N, Hazlitt HA, Prior MI, et al. Treatment of supraventricular tachycardia due to atrioventricular nodal reentry, by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med 1992;327:313-318.
68. Danias PG, Caulfield TA, Weigner MJ, Silverman DI, Manning WJ. Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm. J Am Coll Cardiol 1998;31:588-592.
69. Juul-Moller S, Edvardson N, Rehnqvist-Ahlberg N. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. Circulation 1990;82:1932-1939.
70. Ausma J, Wijffels M, Thone F, Wouters L, Allessie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goal. Circulation 1997;96:3157-3163.